Canada markets closed

Leap Therapeutics, Inc. (LPTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.5100-0.0600 (-2.33%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 98.34M
Enterprise Value 44.00M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)160.10
Price/Book (mrq)2.08
Enterprise Value/Revenue -66.81
Enterprise Value/EBITDA 0.47

Trading Information

Stock Price History

Beta (5Y Monthly) 0.54
52-Week Change 3-68.66%
S&P500 52-Week Change 328.04%
52 Week High 310.2000
52 Week Low 31.2350
50-Day Moving Average 32.8051
200-Day Moving Average 32.5206

Share Statistics

Avg Vol (3 month) 3310.66k
Avg Vol (10 day) 3202.25k
Shares Outstanding 538.26M
Implied Shares Outstanding 639.16M
Float 819.85M
% Held by Insiders 115.88%
% Held by Institutions 126.68%
Shares Short (Apr 30, 2024) 41.36M
Short Ratio (Apr 30, 2024) 42.67
Short % of Float (Apr 30, 2024) 44.23%
Short % of Shares Outstanding (Apr 30, 2024) 43.56%
Shares Short (prior month Mar 28, 2024) 41.14M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jun 21, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-75.03%
Return on Equity (ttm)-136.82%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -85.92M
Net Income Avi to Common (ttm)-81.41M
Diluted EPS (ttm)-3.9800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)70.64M
Total Cash Per Share (mrq)2.76
Total Debt (mrq)262k
Total Debt/Equity (mrq)0.44%
Current Ratio (mrq)5.64
Book Value Per Share (mrq)2.35

Cash Flow Statement

Operating Cash Flow (ttm)-43.75M
Levered Free Cash Flow (ttm)-46.85M